Barclays
ZURA icon

Barclays’s Zura Bio ZURA Stock Holding History

Barclays’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
169,833
+121,172
+249% +$732K ﹤0.01% 2758
2025
Q4 		$255K Buy
48,661
+48,659
+2,432,950% +$192K ﹤0.01% 4198
2025
Q3 		$9 Hold
2
– – ﹤0.01% 5402
2025
Q2 		$2 Sell
2
-55,757
-100% -$66.7K ﹤0.01% 5191
2025
Q1 		$71.9K Sell
55,759
-22,764
-29% -$35.9K ﹤0.01% 4507
2024
Q4 		$196K Buy
78,523
+14,462
+23% +$51.5K ﹤0.01% 4323
2024
Q3 		$260K Buy
64,061
+56,757
+777% +$212K ﹤0.01% 4158
2024
Q2 		$25.6K Sell
7,304
-5,032
-41% -$20.5K ﹤0.01% 4396
2024
Q1 		$31.7K Sell
12,336
-11,275
-48% -$40K ﹤0.01% 4695
2023
Q4 		$110K Buy
23,611
+21,406
+971% +$107K ﹤0.01% 4618
2023
Q3 		$14.6K Buy
2,205
+696
+46% +$4.65K ﹤0.01% 4238
2023
Q2 		$12.4K Buy
+1,509
New +$12.1K ﹤0.01% 4205

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Barclays's ZURA Position: Q1 2026 in Review

Barclays increased its Zura Bio (ZURA) stake by 249% in Q1 2026, buying an estimated $732K and bringing the position to 169,833 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2758.

Barclays first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Barclays held 169,833 shares of Zura Bio worth $1.01M as of Q1 2026.
  • Barclays bought 121,172 Zura Bio shares in Q1 2026, an estimated $732K.
  • Zura Bio made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2758 holding.
  • Barclays first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.